Harpoon Therapeutics, Inc.
HARPNASDAQHealthcare
$23.01
+$0.02(+0.09%)
Market Cap$865079358
P/E Ratio—
52W High$23.21
52W Low$3.11
Harpoon Therapeutics, Inc.（HARP）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · HARP · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2022-12 | 2021-12 | 2020-12 | 2019-12 | 2018-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $31.91M | $23.65M | $17.44M | $5.78M | $4.75M |
| Cost of Revenue | $3.10M | $2.65M | $0.00M | $0.00M | $0.00M |
| Gross Profit | $28.82M | $21.01M | $17.44M | $5.78M | $4.75M |
| Gross Margin %(computed) | 90.30% | 88.81% | 100.00% | 100.00% | 100.00% |
| Operating Expenses | |||||
| R&D Expenses | $81.39M | $72.12M | $52.56M | $41.59M | $26.37M |
| G&A Expenses | $18.85M | $18.33M | $16.21M | $22.39M | $6.11M |
| Total Operating Expenses | $100.24M | $90.45M | $68.78M | $63.98M | $32.47M |
| Operating Income | ($68.33M) | ($116.75M) | ($51.33M) | ($58.21M) | ($27.72M) |
| Operating Margin %(computed) | -214.08% | -493.58% | -294.26% | — | -583.66% |
| Interest Income | $0.78M | $0.24M | $1.45M | $2.68M | $0.40M |
| Interest Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | ($67.73M) | ($116.72M) | ($49.91M) | ($55.57M) | ($27.37M) |
| Income Tax Expense | ($0.59M) | $49.71M | ($3.53M) | ($3.58M) | $0.00M |
| Net Income | ($67.14M) | ($166.44M) | ($46.38M) | ($52.00M) | ($27.37M) |
| Net Margin %(computed) | -210.36% | -703.62% | -265.86% | -900.05% | -576.13% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-20.24 | $-51.57 | $-18.52 | $-23.91 | $-11.45 |
| Wtd Avg Shares | 3.32M | 3.23M | 2.50M | 2.17M | 2.39M |
| EBITDA | ($65.97M) | ($14.65M) | ($49.25M) | ($58.21M) | ($27.37M) |
| EBITDA Margin %(computed) | -206.70% | -61.95% | -282.33% | — | -576.13% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · M
深入了解Harpoon Therapeutics, Inc.
关于Harpoon Therapeutics, Inc.（HARP）损益表
Harpoon Therapeutics, Inc.（HARP）损益表数据来源于SEC Form 10-K及10-Q申报文件。2022财年，HARP实现营收$0.03B，毛利润$0.03B（毛利率90.30%），净利润($0.07B)（净利率-210.36%）。
常见问题
HARP · 4 问Harpoon Therapeutics, Inc.（HARP）2022财年营收为$0.03B，同比up34.9%。
HARP revenueHARP salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09